跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,825 条关于
“Dawn Biopharma”
全部
2,825
临床试验
674
药物
418
机构
207
资讯
1,526
2年前
Bambusa Therapeutics Secures $15 Million Seed Funding for Bispecific Antibody Development
去年
Bambusa Therapeutics Secures $90M Series A to Advance Novel Bispecific Antibody Pipeline
去年
Antag Therapeutics Secures €80 Million to Advance Novel Obesity Therapy
上个月
Expedition Therapeutics Raises $115M Series B as DPP1 Inhibitor EXPD-101 Enters Phase 2 COPD Trial
11个月前
Expedition Therapeutics Secures $165 Million Series A to Advance First-in-Class DPP1 Inhibitor for COPD
8个月前
Antag Therapeutics Reports Promising Phase 1 Results for Novel GIPR Antagonist AT7687 in Obesity Treatment
4个月前
Antag Therapeutics' First-in-Class GIPR Antagonist AT7687 Shows Promising Phase 1 Results and Preclinical Combination Data at ADA 2026
3个月前
Vedana Therapeutics Launches with $46M Series A to Develop Next-Generation PACAP-Targeting Migraine Therapies
10个月前
Day One Biopharmaceuticals Acquires Mersana Therapeutics for $25 Per Share in $285 Million Deal
去年
Dawn Health Secures €11.5 Million to Expand Pharma-Focused Digital Health Platform
第 1 页,共 153 页
上一页
下一页